theory clinical_55_1
imports Main

begin

typedecl entity
typedecl event

consts
  Patient :: "entity ⇒ bool"
  Mutation :: "entity ⇒ bool"
  Pathogenic :: "entity ⇒ bool"
  PALB2 :: "entity ⇒ bool"
  With :: "entity ⇒ entity ⇒ bool"
  Partner :: "entity ⇒ bool"
  Binding :: "entity ⇒ bool"
  Encodes :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  PatientEvent :: "event ⇒ entity ⇒ bool"  (* Renamed to avoid conflict with Patient *)
  BRCA2 :: "entity ⇒ bool"
  Sites :: "entity ⇒ bool"
  Damage :: "entity ⇒ bool"
  DNA :: "entity ⇒ bool"
  Localises :: "event ⇒ bool"
  To :: "entity ⇒ entity ⇒ bool"
  BRCA1 :: "entity ⇒ bool"
  HRRepair :: "entity ⇒ bool"
  Links :: "event ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Homologous :: "entity ⇒ bool"
  Repair :: "entity ⇒ bool"
  Joining :: "event ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Homolog1 :: "entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Loss :: "entity ⇒ bool"
  Action :: "event ⇒ bool"
  Prevents :: "event ⇒ event ⇒ bool"
  HRR :: "entity ⇒ bool"

(* Explanation 1: Patient with a pathogenic mutation in PALB2 *)
axiomatization where
  explanation_1: "∃x y. Patient x ∧ Mutation y ∧ Pathogenic y ∧ PALB2 y ∧ With x y"

(* Explanation 2: PALB2 encodes a binding partner that localises BRCA2 to sites of DNA damage and links BRCA1 and BRCA2 in HR repair and DNA damage *)
axiomatization where
  explanation_2: "∃x y z w e1 e2 e3. PALB2 x ∧ Partner y ∧ Binding y ∧ Encodes e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ BRCA2 z ∧ Sites w ∧ Damage w ∧ DNA w ∧ Localises e2 ∧ Agent e2 y ∧ PatientEvent e2 z ∧ To z w ∧ BRCA1 z ∧ HRRepair w ∧ Links e3 ∧ Agent e3 y ∧ PatientEvent e3 z ∧ In z w"

(* Explanation 3: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans *)
axiomatization where
  explanation_3: "∃x y z w e1 e2. BRCA2 x ∧ Molecules y ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ Joining e1 ∧ Agent e1 x ∧ PatientEvent e1 y ∧ RAD51 z ∧ Homolog1 z ∧ Via e1 z ∧ Humans w ∧ In z w"

theorem hypothesis:
  assumes asm: "Loss x ∧ PALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z"
  (* Hypothesis: Loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR *)
  shows "∃x y z e1 e2. Loss x ∧ PALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z ∧ Prevents e1 e2"
proof -
  (* From the premise, we have known information about the loss of PALB2 and the action of BRCA2. *)
  from asm have "Loss x ∧ PALB2 x ∧ Action e1 ∧ BRCA2 y ∧ Molecules z ∧ Undamaged z ∧ Repair z ∧ HRR z ∧ Joining e2 ∧ Agent e2 y ∧ PatientEvent e2 z" by blast
  (* Explanation 3 states that BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  (* However, the loss of PALB2 implies that this action is prevented. *)
  (* Therefore, we can conclude that the loss of PALB2 prevents the action of BRCA2 in joining undamaged repair molecules in HRR. *)
  then have "Prevents e1 e2" sledgehammer
  then show ?thesis <ATP>
qed

end
